Serious hepatitis A: An analysis of patients hospitalized during an urban epidemic in the United States

Annals of Internal Medicine

Volumn 128, Issue 2, 1998, Pages 111-114

  Willner, Ira R ^a   Uhl, Mark D ^a   Howard, Scott C ^a   Williams, Ernest Q ^a   Riely, Caroline A ^a   Waters, Bradford ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; EPIDEMIC; HEALTH CARE COST; HEPATITIS A; HIGH RISK POPULATION; HUMAN; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0031973032     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-128-2-199801150-00006     Document Type: Article

References (20)

1. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1996;45(RR-15):1-30.
2. Skinner JT. Community-wide epidemic of hepatitis A - Shelby County, Tennessee. J Tenn Med Assoc. 1995;88:468-9.
3. Increased hepatitis incidence in Arkansas and surrounding states. J Ark Med Soc. 1995;92:345-6.
4. Shaw FE Jr, Sudman JH, Smith SM, Williams DL, Kapell LA, Hadler SC, et al. A community-wide epidemic of hepatitis A in Ohio. Am J Epidemiol. 1986;123:1057-65.
5. Tong MJ, el-Farra NS, Grew MI. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J Infect Dis. 1995; 171(Suppl 1):S15-8.
6. Melnick JL. History and epidemiology of hepatitis A virus. J Infect Dis. 1995; 171(Suppl 1):S2-S8.
7. Forbes A, Williams R. Changing epidemiology and clinical aspects of hepatitis A. Br Med Bull. 1990;46:303-18.
8. Muraoka H. [Clinical and epidemiological study on factors of serious development of viral hepatitis type A.] Nippon Shokakibyo Gakkai Zasshi. 1990;87: 1383-91.
9. Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med. 1992;327:453-7.
10. Dalton CB, Haddix A, Hoffman RE, Mast EE. The cost of a food-borne outbreak of hepatitis A in Denver, Colo. Arch Intern Med. 1996;156:1013-6.
11. Mourani S, Dobbs SM, Genta RM, Tandon AK, Yoffe B. Hepatitis A virus-associated cholecystitis. Ann Intern Med. 1994;120:398-400.
12. Faust RL, Pimstone N. Acute renal failure associated with nonfulminant hepatitis A viral infection. Am J Gastroenterol. 1996;91:369-72.
13. Inman RD, Hodge M, Johnston ME, Wright J, Heathcote J. Arthritis, vasculitis, and cryoglobulinemia associated with relapsing hepatitis A virus infection. Ann Intern Med. 1986;105:700-3.
14. Huppertz HI, Treichel U, Gassel AM, Jeschke R, Meyer zum Buschenfelde KH. Autoimmune hepatitis following hepatitis A virus infection. J Hepatol. 1995;23:204-8.
15. Vento S, Garofano T, Di Perri G, Dolci L, Concia E, Bassetti D. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet. 1991;337:1183-6.
16. Vento S, Cainelli R, Ferraro T, Concia E. Autoimmune hepatitis type 1 after measles. Am J Gastroenterol. 1996;91:2618-20.
17. Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine. 1992;10(Suppl 1):S59-S62.
18. Koff RS. Seroepidemiology of hepatitis A in the United States. J Infect Dis. 1995;17(Suppl 1):S19-S23.
19. Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine. 1992;10(Suppl 1):S15-S17.
20. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am. 1994;23:437-55.